D-150 is a potential backbone therapy that is designed to provide multi-year sustained delivery of anti-VEGF (aflibercept and ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on 4D Molecular Therapeutics (FDMT – Research ...

More information: Jing-Ping Lin et al, 4D marmoset brain map reveals MRI and molecular signatures for onset of multiple ...

2D ultrasounds are part of routine prenatal care. What about 3D and 4D ultrasound technology? Learn about the safety and use ...

A Chinese research team has developed a single-step femtosecond laser 4D printing technology that enables rapid and precise ...

Euros just a few months away, attention continues to grow around women's soccer. Now new research involving Swansea ...

The seamless in-line mode enables 3D/4D OI/CT acquisitions on a single-floor standing platform and offers more accurate reconstruction and quantification of deep tissues and dark organs.